Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
Authors
Keywords
Irinotecan sucrosofate, Liposome, PEP02, MM-398, Pharmacokinetics, <em class=EmphasisTypeItalic >UGT1A1</em> gene
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 75, Issue 3, Pages 579-586
Publisher
Springer Nature
Online
2015-01-10
DOI
10.1007/s00280-014-2671-x
References
View 2 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.